Younger women may face higher costs for breast cancer treatment than older patients

Younger women may face higher costs for breast cancer care than older patients at least in part because they're diagnosed when tumors are more advanced and require more aggressive treatment, a recent U.S. study suggests.

For younger women aged 21 to 44, average treatment costs in the first year after a breast cancer diagnosis were $97,486 higher than average medical costs for similar women who didn't have breast cancer, the study found.

By contrast, older women aged 45 to 64 had average treatment costs in the first year after a breast cancer diagnosis that were $75,737 more than their peers without breast cancer spent on healthcare in a year.

About 40 percent of the young cancer patients were diagnosed with what's known as stage two tumors, when cancer has spread to lymph nodes surrounding the breast while just 34 percent of older women were diagnosed when cancer had reached stage two.

"Some of the difference in costs may be due to younger women being diagnosed at a higher stage of disease," said Stacie Dusetzina, a pharmacy and public health researcher at the University of North Carolina at Chapel Hill who wasn't involved in the study.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Air pollution linked to head and neck cancer risk